Title : Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.

Pub. Date : 2019 Jan 1

PMID : 30418475






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Objective: To evaluate the effect of linagliptin, a selective DPP-4 inhibitor, on CV outcomes and kidney outcomes in patients with type 2 diabetes at high risk of CV and kidney events. Linagliptin dipeptidyl peptidase 4 Homo sapiens